4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-14-001853
CIK 0001009356operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:44 PM ET
Size
8.5 KB
Accession
0001209191-14-001853
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2014-01-02$89.94/sh−34,055$3,062,907→ 901,405.2 total
Holdings
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying)
Footnotes (2)
- [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:44 PM ET
- Size
- 8.5 KB